Cargando…

Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement

Mesenchymal stem cells (MSCs) are paraxial mesodermal progenitors with potent immunomodulatory properties. Reports also indicate that MSCs can undergo neural-like differentiation, offering hope for use in neurodegenerative diseases. However, ex vivo expansion of these rare somatic stem cells for cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Kai-Yen, Lee, Yu-Wei, Hsu, Pei-Ju, Wang, Hsiu-Huan, Wang, Yun, Liou, Jun-Yang, Hsu, Shan-Hui, Wu, Kenneth K., Yen, B. Linju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190070/ https://www.ncbi.nlm.nih.gov/pubmed/27304057 http://dx.doi.org/10.18632/oncotarget.9947

Ejemplares similares

Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells
por: Boraas, Liana C., et al.
Publicado: (2016)

HLA-G Expression in Human Mesenchymal Stem Cells (MSCs) Is Related to Unique Methylation Pattern in the Proximal Promoter as well as Gene Body DNA
por: Yen, B. Linju, et al.
Publicado: (2020)

Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
por: Wang, Li‐Tzu, et al.
Publicado: (2021)

Efficient Differentiation of Human Induced Pluripotent Stem Cell (hiPSC) Derived Hepatocyte-Like Cells on hMSCs Feeder
por: Mobarra, Naser, et al.
Publicado: (2014)

Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials
por: Wang, Li-Tzu, et al.
Publicado: (2016)

Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations
por: Kałuzińska-Kołat, Żaneta, et al.
Publicado: (2023)

Transgene-free induced pluripotent dental stem cells for neurogenic differentiation
por: Morsczeck, Christian
Publicado: (2012)

An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells
por: Hsu, Li-Jie, et al.
Publicado: (2021)

iPSC-MSCs and islet allograft tolerance
por: Wang, Tong-Song, et al.
Publicado: (2015)

Molecular and Functional Verification of Wharton’s Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019)

Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs)
por: Prakash, Nityanand, et al.
Publicado: (2023)

Characterizing the secretome of licensed hiPSC-derived MSCs
por: Ramos, Yolande F. M., et al.
Publicado: (2022)

Assessing Cell Competition in Human Pluripotent Stem Cell (hPSC) Cultures
por: Price, Christopher J., et al.
Publicado: (2022)

Three-Dimensional Spheroid Culture of Human Mesenchymal Stem Cells: Offering Therapeutic Advantages and In Vitro Glimpses of the In Vivo State
por: Yen, B Linju, et al.
Publicado: (2023)

iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs
por: Lee, Hae-Ri, et al.
Publicado: (2023)

iPSC-Derived MSCs Versus Originating Jaw Periosteal Cells: Comparison of Resulting Phenotype and Stem Cell Potential
por: Umrath, Felix, et al.
Publicado: (2020)

Human pluripotent stem cell (hPSC) and organoid models of autism: opportunities and limitations
por: Kilpatrick, Savannah, et al.
Publicado: (2023)

Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature
por: Spitzhorn, Lucas-Sebastian, et al.
Publicado: (2019)

The Cytoskeletal Protein RHAMM and ERK1/2 Activity Maintain the Pluripotency of Murine Embryonic Stem Cells
por: Jiang, Jihong, et al.
Publicado: (2013)

Adult Neural Stem Cells from Midbrain Periventricular Regions Show Limited Neurogenic Potential after Transplantation into the Hippocampal Neurogenic Niche
por: Fauser, Mareike, et al.
Publicado: (2021)

Neurogenic and non-neurogenic functions of endogenous neural stem cells
por: Butti, Erica, et al.
Publicado: (2014)

The Contribution of Pluripotent Stem Cell (PSC)-Based Models to the Study of Fragile X Syndrome (FXS)
por: Abu Diab, Manar, et al.
Publicado: (2019)

Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
por: Coccia, Elena, et al.
Publicado: (2021)

Dorsal-ventral patterned neural cyst from human pluripotent stem cells in a neurogenic niche
por: Zheng, Y., et al.
Publicado: (2019)

ECM-Dependent HIF Induction Directs Trophoblast Stem Cell Fate via LIMK1-Mediated Cytoskeletal Rearrangement
por: Choi, Hwa J., et al.
Publicado: (2013)

hiPSC‐derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine
por: Sabapathy, Vikram, et al.
Publicado: (2016)

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
por: Chen, Pei-Min, et al.
Publicado: (2011)

Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
por: Weiss, Andreas Robert Rudolf, et al.
Publicado: (2019)

Altered cytoskeletal arrangement in induced pluripotent stem cells and motor neurons from patients with riboflavin transporter deficiency
por: Niceforo, Alessia, et al.
Publicado: (2021)

Mouse embryonic dorsal root ganglia contain pluripotent stem cells that show features similar to embryonic stem cells and induced pluripotent stem cells
por: Ogawa, Ryuhei, et al.
Publicado: (2017)

Molecular Mechanisms of Host Cytoskeletal Rearrangements by Shigella Invasins
por: Lee, Jun Hyuck, et al.
Publicado: (2014)

Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin
por: Jakob, Mark, et al.
Publicado: (2020)

Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
por: Wang, Wei-Bei, et al.
Publicado: (2015)

Differentiation of Definitive Endoderm from Human Induced Pluripotent Stem Cells on hMSCs Feeder in a Defined Medium
por: Jaafarpour, Zahra, et al.
Publicado: (2016)

Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products
por: Kawamata, Shin, et al.
Publicado: (2015)

Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis
por: Kammers, Kai, et al.
Publicado: (2017)

A Rapid and Highly Predictive in vitro Screening Platform for Osteogenic Natural Compounds Using Human Runx2 Transcriptional Activity in Mesenchymal Stem Cells
por: Wang, Li-Tzu, et al.
Publicado: (2021)

PM492. Schizophrenia patient-derived induced pluripotent stem cells exhibit changes in neurogenic and gliogenic competences
por: Toyoshima, Manabu, et al.
Publicado: (2016)

Neurogenic Potential of the 18-kDa Mitochondrial Translocator Protein (TSPO) in Pluripotent P19 Stem Cells
por: González-Blanco, Laura, et al.
Publicado: (2021)

EV products obtained from iPSC-derived MSCs show batch-to-batch variations in their ability to modulate allogeneic immune responses in vitro
por: Tertel, Tobias, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3tfsshraqkmu65fbfdhs3c3gd0